The associations with PNPLA3 for both NAFLD and disease severity were highly consistent with previous publications that have recruited well-characterized participants, thus serving as validation of our overall approach. The gene discussed is PNPLA3; the disease is metabolic dysfunction-associated steatotic liver disease.